To analyze the role of TRF3 during embryonic development, we used antisense morpholino oligonucleotides (MOs) to ablate Trf3, and as a control Tbp, function in zebrafish embryos. MOs were injected into wild-type one-cell stage fertilized embryos and depletion of Trf3 and Tbp was analyzed by immunoblotting at 6 hours post-fertilization (hpf), a time at which expression of both proteins was readily detectable (
Supplementary Fig. 1a). Immunoblot analysis confirmed that injection of each MO efficiently and specifically depleted its target gene (
Supplementary Fig. 1b). Consistent with previous studies
5, Tbp-depleted embryos appeared to initiate gastrulation but failed to progress past 50% epiboly (
Supplementary Fig. 2; n=122/150). By contrast, Trf3-depleted embryos appeared to develop normally until the tailbud stage, but by 14 hpf exhibited delayed development and necrosis compared to siblings injected with a randomized control MO (n=166/177). Inspection of Trf3-depleted embryos at 21 hpf revealed severe necrosis, although head, trunk and tail rudiments were apparent, suggesting that initial antero-posterior patterning was largely unaffected.
To identify Trf3 target genes, we performed expression profiling in
trf3 MO-treated embryos (at 6 hpf) using a zebrafish oligonucleotide microarray representing ~12,800 genes. As expected, the vast majority of genes were unaffected by Trf3 depletion (
Supplementary Data). Three such representative genes are shown as controls in the RT-PCR experiment of , which confirms that their expression is dependent upon Tbp but not Trf3. Using a candidate-based approach, we selected genes whose expression were significantly decreased by Trf3 knockdown (
Supplementary Table 1) and had been previously implicated in embryonic development. These candidates were further analyzed by RT-PCR for Trf3-dependent expression, chromatin immunoprecipitation (ChIP) for selective Trf3 occupancy, and finally for a role in zebrafish development (see below and data not shown). This combined analysis identified
mespa, whose mouse orthologue,
Mesp1, encodes a basic-helix-loop-helix (bHLH)-type transcription factor required for proper embryonic development
4.
The RT-PCR results of show that Trf3 depletion eliminated mespa expression. To determine whether mespa was a direct Trf3 target, we analyzed promoter occupancy by ChIP assays using antibodies directed against Trf3, Tbp, RNA polymerase II (Pol II) or, as a negative control, an irrelevant protein (yeast Gal4). As controls, we analyzed two well-characterized housekeeping genes, actin and gapdh. shows that Pol II was bound to all three promoters, consistent with the transcriptional activity of these genes. Notably, Tbp but not Trf3 was bound to the actin promoter, whereas both Tbp and Trf3 were bound to the gapdh promoter. By contrast, the mespa promoter was selectively bound by Trf3 and not Tbp. Based upon the dependence of mespa expression on Trf3 () and the selective binding of Trf3 to the mespa promoter (), we conclude that mespa is a direct Trf3 target gene.
Phenotypic analysis demonstrated that the
mespa MO-injected embryo had a developmental defect that was strikingly similar to that of a Trf3-depleted embryo (n=61/89) ( and
Supplementary Fig. 3). As a control, injection of a
mespa mRNA bearing a silent mutation that prevented hybridization with the
mespa MO restored normal development to the Mespa-depleted embryo (
Supplementary Fig. 4). To compare the phenotypes of the Trf3- and Mespa-depleted embryos in greater detail, we performed whole mount
in situ hybridization using several developmentally-regulated genes as markers. shows that depletion of either Trf3 or Mespa resulted in increased
shh expression in axial mesoderm, decreased
nkx2.5 expression in cardiac mesoderm, and decreased
gata1 expression in lateral mesoderm. Surprisingly, expression of a second lateral mesoderm marker,
pax2, was unaffected by loss of Trf3 or Mespa. Moreover, expression of the ventral marker
bmp4 was normal in both Trf3- and Mespa-depleted embryos, indicating that the developmental defects were not due to loss of proper dorsal-ventral patterning. Thus, the developmental defect observed in Mespa-depleted embryos was very similar, if not identical, to that of Trf3-depleted embryos.
We next asked whether ectopic expression of
mespa could restore normal development to a Trf3-depleted embryo. shows that injection of
mespa mRNA (n=110/134), but not an unrelated control mRNA (n=0/63; data not shown), restored normal development to the
trf3 MO-injected embryo. Completeness of rescue was verified by differential interference contrast microscopy (
Supplementary Fig. 5) and
in situ hybridization analysis (
Supplementary Fig. 6). Collectively, these results indicate that in zebrafish,
mespa is the single Trf3 target gene required for proper embryonic development.
The results of suggested a requirement for Trf3 and Mespa during development of cell types in the lateral mesoderm, which we elected to analyze in greater detail. We assayed the expression of several hematopoietic, vascular and pronephric markers in
trf3- or
mespa-MO injected embryos. The RT-PCR results of
Supplementary Fig. 7 indicate that a number of blood cell-specific genes were significantly down-regulated in Trf3- and Mespa-depleted embryos, including
hbae1 and
hbae3, which are terminal markers of erythroid cell fate, as well as
gata1, which is required for the expression of a variety of genes in the erythroid lineage. In addition, earlier markers of hematopoietic precursors,
scl and
lmo2, were similarly reduced although expression of
gata2 was unaffected. Finally, expression of
pu.1, a marker of myeloid cells that arise in the anterior lateral mesoderm, was also reduced in the absence of Trf3 or Mespa.
To confirm the RT-PCR results, we analyzed the expression of these marker genes by whole mount
in situ hybridization. shows that in
trf3- or
mespa-MO injected embryos,
scl expression was reduced in the posterior lateral mesoderm, although expression was maintained within more anterior cells whose position is consistent with that of endothelial cells
6,7. Expression of
lmo2 was moderately reduced in the posterior lateral mesoderm in Trf3- and Mespa-depleted embryos, whereas
pu.1 expression was absent from anterior lateral mesoderm. Also consistent with the RT-PCR results, expression of the early hematopoietic marker
gata2 was unaffected by loss of Trf3 or Mespa. Similarly, expression of the endothelial cell marker
kdr was normal in embryos lacking Trf3 or Mespa. As expected, injection of
mespa mRNA into Trf3-depleted embryos fully rescued expression of the hematopoietic markers
gata1 (see below),
hbae3 and
scl (
Supplementary Fig. 6), as well as the cardiac mesoderm marker
nkx2.5 (
Supplementary Fig. 6).
Collectively, the results of suggest a defect in the formation of hematopoietic cells in the posterior lateral mesoderm. To confirm this defect, we simultaneously assayed expression of fli1, a marker for both hematopoietic and endothelial cells, and either gata1 or pax2, markers of erythroid or pronephric lateral mesoderm, respectively. shows that expression of a fli1:EGFP transgene was maintained in the absence of Trf3 or Mespa, whereas gata1 expression was absent from the same embryo. By contrast, pax2 was unaffected by the loss of Trf3 or Mespa and continued to be co-expressed with fli1 in adjacent cells of the lateral mesoderm. Taken together, these results demonstrate a selective loss of hematopoietic cells within the posterior lateral mesoderm of zebrafish embryos lacking Trf3 or Mespa.
The defects in hematopoietic development described above are reminiscent of those observed in embryos lacking Cdx4, a caudal-related transcription factor that is required for hematopoiesis
6 and functions by activating expression of homeobox genes involved in the commitment of mesoderm to the hematopoietic lineage
6,8. RT-PCR and
in situ hybridization analysis showed that
cdx4 expression was substantially decreased in Trf3-depleted embryos, as well as in Mespa-depleted embryos (). As expected, expression of the Cdx4-dependent genes
hoxa9a,
hoxb7a and
hoxb5a8 was also substantially reduced in Trf3- and Mespa-depleted embryos (
Supplementary Fig. 8). Depletion of Trf3 or Mespa did not affect expression of
cdx1a (
Supplementary Fig. 9), which has been reported to cooperate with
cdx4 in hematopoietic development
8.
In situ hybridization analysis revealed that at 6 hpf,
cdx4,
mespa and
trf3 were co-expressed in the presumptive hematopoietic tissues based on the zebrafish fate map
9,10 (), suggesting that the three factors are components of a common pathway. To confirm this idea and determine the order of the pathway, we performed epistasis experiments using
gata1 expression as a phenotypic read-out. shows that injection of
trf3 mRNA restored
gata1 expression in Trf3-depleted embryos, but not in Mespa- and Cdx4-depleted embryos, indicating that
trf3 is upstream of both
mespa and
cdx4. Moreover, injection of
mespa mRNA restored
gata1 expression in Trf3- and Mespa-depleted embryos, but not in Cdx4-depleted embryos, indicating that
mespa is upstream of
cdx4 and downstream of
trf3. Finally, injection of
cdx4 mRNA restored
gata1 expression in Trf3-, Mespa- and Cdx4-depleted embryos, indicating that
cdx4 is downstream of both
trf3 and
mespa. ChIP analysis supports the possibility that
cdx4 is a direct Mespa target gene (
Supplementary Fig. 10a).
Previous studies have shown that ectopic expression of
cdx4 in zebrafish results in increased number of blood cells, as evidenced by expanded expression of hematopoietic markers
6. Ectopic expression of
mespa also resulted in expanded expression of
gata1 and
scl () and
cdx4 (). The collective results of and reveal that
trf3,
mespa and
cdx4 function in a common pathway, which is summarized in
Supplementary Fig. 10b.
Collectively, our results indicate that binding of Trf3 to the
mespa promoter is the earliest documented step in committing mesoderm to the hematopoietic lineage in the developing zebrafish embryo. A recent study has provided definitive evidence for the existence of hemangioblasts, bipotential progenitors that can give rise to both endothelial and hematopoietic cells, within the zebrafish embryo
10. Significantly, in zebrafish embryos, hemangioblasts are present at the same time and place in which
trf3,
mespa and
cdx4 are expressed. Thus, the timing and location of
trf3,
mespa and
cdx4 co-expression suggests that this transcription factor pathway may function within hemangioblasts to specify hematopoietic progenitor cells (i.e., commitment of mesoderm to the hematopoietic lineage). Although the defects associated with loss of Trf3 or Mespa are restricted to hematopoietic cell types in the lateral mesoderm, the effects on other tissues appear to be more widespread. We predict that there will be additional Mespa target genes that function analogous to but independent of
cdx4 in mediating other developmental pathways, such as specification of cardiac mesoderm, in the early embryo.